These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27162552)

  • 21. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
    J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal delivery of mixnoxidil with block copolymer nanoparticles.
    Shim J; Seok Kang H; Park WS; Han SH; Kim J; Chang IS
    J Control Release; 2004 Jul; 97(3):477-84. PubMed ID: 15212879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial.
    Liang X; Chang Y; Wu H; Liu Y; Zhao J; Wang L; Zhuo F
    Front Med (Lausanne); 2022; 9():905140. PubMed ID: 35899211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Albumin acts like transforming growth factor β1 in microbubble-based drug delivery.
    Chuang YH; Wang YH; Chang TK; Lin CJ; Li PC
    Ultrasound Med Biol; 2014 Apr; 40(4):765-74. PubMed ID: 24433746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delivery of minoxidil encapsulated in cyclodextrins with photoacoustic waves enhances hair growth.
    Melo-Guímaro S; Cardoso R; Lobo CS; Pereira DA; Varela C; Santos J; P João C; Serpa C; Arnaut LG
    Eur J Pharm Biopharm; 2024 Sep; 202():114390. PubMed ID: 38950716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and evaluation of a multimodal minoxidil microemulsion versus minoxidil alone in the treatment of androgenic alopecia of mixed etiology: a pilot study.
    Sakr FM; Gado AM; Mohammed HR; Adam AN
    Drug Des Devel Ther; 2013; 7():413-23. PubMed ID: 23807837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laser-assisted drug delivery for the treatment of androgenetic alopecia: ablative laser fractional photothermolysis to enhance cutaneous topical delivery of platelet-rich plasma - with or without concurrent bimatoprost and/or minoxidil.
    Cohen PR
    Dermatol Online J; 2019 Feb; 25(2):. PubMed ID: 30865404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential synergistic effects of human placental extract and minoxidil on hair growth-promoting activity in C57BL/6J mice.
    Kwon TR; Oh CT; Park HM; Han HJ; Ji HJ; Kim BJ
    Clin Exp Dermatol; 2015 Aug; 40(6):672-81. PubMed ID: 25787854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the efficacy of topical minoxidil 5% and adenosine 0.75% solutions on male androgenetic alopecia and measuring patient satisfaction rate.
    Faghihi G; Iraji F; Rajaee Harandi M; Nilforoushzadeh MA; Askari G
    Acta Dermatovenerol Croat; 2013; 21(3):155-9. PubMed ID: 24183218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chitosan microparticles for sustaining the topical delivery of minoxidil sulphate.
    Gelfuso GM; Gratieri T; Simão PS; de Freitas LA; Lopez RF
    J Microencapsul; 2011; 28(7):650-8. PubMed ID: 21824068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Microbubble Size on Ultrasound-Induced Transdermal Delivery of High-Molecular-Weight Drugs.
    Liao AH; Ho HC; Lin YC; Chen HK; Wang CH
    PLoS One; 2015; 10(9):e0138500. PubMed ID: 26390051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug Delivery System Based On Minoxidil Nanoparticles Promotes Hair Growth In C57BL/6 Mice.
    Nagai N; Iwai Y; Sakamoto A; Otake H; Oaku Y; Abe A; Nagahama T
    Int J Nanomedicine; 2019; 14():7921-7931. PubMed ID: 31632009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies.
    Gomes MJ; Martins S; Ferreira D; Segundo MA; Reis S
    Int J Nanomedicine; 2014; 9():1231-42. PubMed ID: 24634584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of topical bimatoprost with enhanced skin infiltration and
    Subedi L; Pandey P; Shim JH; Kim KT; Cho SS; Koo KT; Kim BJ; Park JW
    Drug Deliv; 2022 Dec; 29(1):328-341. PubMed ID: 35040730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.
    Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
    Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial.
    Panahi Y; Taghizadeh M; Marzony ET; Sahebkar A
    Skinmed; 2015; 13(1):15-21. PubMed ID: 25842469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
    Roberts J; Desai N; McCoy J; Goren A
    Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
    Gassmueller J; Hoffmann R; Webster A
    Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
    Tanglertsampan C
    J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.